Researcher Calls for Overhaul of Peer-Review Process for COVID Vaccines at National Citizens Inquiry
Massachusetts-based genetics researcher Kevin McKernan states that the peer review process is being influenced by pharmaceutical interests, especially concerning research on the adverse effects of COVID-19 vaccination.
“The current peer review process is completely flawed and being controlled by pharmaceutical interests,” explained Mr. McKernan during the National Citizens Inquiry held in Regina on May 30.
He highlighted his discovery that COVID-19 vaccines contain genetic material fragments, stating that “it’s extremely challenging to make controversial information like this public.”
Mr. McKernan, the founder and chief scientific officer of Medicinal Genomics, led research and development for the Human Genome Project at Whitehead Institute/MIT from 1996 to 2000. His work has been cited 57,000 times and resulted in 29 patents.
In 2023, Mr. McKernan and his co-authors published a preprint paper titled “Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose.”
He informed the inquiry that replicability of results was more crucial than peer review and mentioned that researchers in Japan, France, and Canada had also identified DNA contamination. Canadian virologist Dr. David Speicher made similar discoveries.